February 23, 2012

New Drug Induces Posterior Vitreous Detachment (PVD)

A potential new drug, ocriplasmin (microplasmin) may soon be available to chemically induce a PVD thus avoiding surgery for many retinal conditions.
October 31, 2012

Ocriplasmin Approved for VMT and Macular Holes

  Ocriplasmin, or Jetrea,  has been FDA approved.  The drug is approved only for a retinal condition called vitreomacular traction (VMT) or vitreomacular adhesion (VMA).  The […]
July 5, 2013

Jetrea (Ocriplasmin) for VMA (vitreomacular adhesion)

I have recently started treating patients with Jetrea, an FDA approved enzyme, for the treatment of vitreomacular adhesion, or VMA.